Out-of-pocket cost considerations

Updated May 2026 · 5 min read · Educational only, not medical advice

If insurance doesn't cover your weight-loss medication, your cost picture comes down to a small number of options, each with trade-offs. This article walks through the typical numbers as of 2026.

Brand-name list prices

The manufacturer "list price" — what they publish — for Wegovy and Zepbound runs in the neighborhood of $1,000–$1,400 per month for full-dose supply. These numbers shift, and pharmacies negotiate from them, so the real cash price varies.

• Big-box and online pharmacy discount tools (GoodRx, manufacturer card) may reduce the price somewhat.
• Some pharmacies negotiate cash prices that are noticeably lower than the published list.
• Specialty pharmacies sometimes have different pricing than retail.

Manufacturer savings programs

Both Novo Nordisk and Eli Lilly run patient programs:

• Commercial-insured patients with partial coverage may see significant copay reduction (often down to $25–$200/month range depending on the program).
• Self-pay patients may see modest discounts off list price through manufacturer-direct programs.
• Medicare and Medicaid patients are generally not eligible due to federal anti-kickback rules.

Eligibility and pricing change frequently. Check the manufacturer's official program pages or ask your provider's office to verify before counting on a specific price.

Compounded GLP-1s through telehealth

Telehealth weight-care clinics often advertise compounded semaglutide or tirzepatide at $200–$500 per month. The price is genuinely lower, but compounded medications are different products from the FDA-approved versions:

• They are made by compounding pharmacies, not FDA-approved manufacturers.
• Quality control, sterility, and dosing accuracy vary by pharmacy.
• The FDA has issued safety communications about compounded GLP-1s.
• Some compounded versions add other substances (vitamins, sometimes peptides) which may not be appropriate or studied.

If you're considering compounded options, ask the telehealth provider:

• Which compounding pharmacy is the medication coming from?
• Is it accredited and inspected?
• Is it pure semaglutide/tirzepatide, or a combination product?
• What's the protocol if I have a reaction or side effect?

Other cost categories

Medication is not the only cost. Plan for:

• Provider visits. Initial appointments often run $100–$300, follow-ups $50–$150. Telehealth subscriptions are sometimes monthly memberships.
• Lab work. If not covered, basic panels are typically $50–$200.
• Pharmacy delivery fees, if applicable.
• Supportive products — protein, electrolytes, etc. — which add up over time.

Comparing apples to apples

When comparing offers, look at the all-in monthly cost. A $200 compounded GLP-1 subscription that includes provider visits and the medication is different from a $1,000 brand-name prescription that doesn't include visits. Convert each option to "what will I actually spend per month over a year" before deciding.

The financial-vs-clinical trade-off

Compounded options are cheaper. Brand-name options have the strongest evidence base and known supply chains. Many patients find the right answer is whichever option their provider supports and which they can afford to sustain. Stopping abruptly often reverses progress, so affordability over the long term matters more than minimizing the first month's bill.

Try the estimator

Our cost estimator gives you a planning range based on medication type and coverage. It's not a quote, but it sets a rough budget expectation.